225 related articles for article (PubMed ID: 26400521)
21. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
Huang C; Yu Z; Yang H; Lin Y
Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
[TBL] [Abstract][Full Text] [Related]
22. Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.
Zhang L; Niyazi HE; Zhao HR; Cao XP; Abudula MN; Ye WJ; Zhang SA; Yiming RH; Zhang Y; Su WP; Chen R; Ouyang Y; Miao N; Bao YX
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252165
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
[TBL] [Abstract][Full Text] [Related]
24. Correlation between long strand non-coding RNA GASS expression and prognosis of cervical cancer patients.
Li Y; Wan YP; Bai Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):943-949. PubMed ID: 29509242
[TBL] [Abstract][Full Text] [Related]
25. Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
Zou R; Chen X; Jin X; Li S; Ou R; Xue J; Yan X; Chen L; Hu Y; Zhu H
Surg Oncol; 2018 Jun; 27(2):306-313. PubMed ID: 29937186
[TBL] [Abstract][Full Text] [Related]
26. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
27. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
Shan S; Li HF; Yang XY; Guo S; Guo Y; Chu L; Xu MJ; Xin DM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):507-512. PubMed ID: 30720157
[TBL] [Abstract][Full Text] [Related]
28. MALAT1 promoted invasiveness of gastric adenocarcinoma.
Lee NK; Lee JH; Ivan C; Ling H; Zhang X; Park CH; Calin GA; Lee SK
BMC Cancer; 2017 Jan; 17(1):46. PubMed ID: 28077118
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA colon cancer associated transcript‑1 promotes the proliferation, migration and invasion of cervical cancer.
Jia L; Zhang Y; Tian F; Chu Z; Xin H
Mol Med Rep; 2017 Oct; 16(4):5587-5591. PubMed ID: 28849215
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
Yang M; Zhai X; Xia B; Wang Y; Lou G
Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
Wang SH; Zhang WJ; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Oncotarget; 2016 Jun; 7(25):37857-37867. PubMed ID: 27191262
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
Zhang HH; Li AH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT
Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion.
Guo F; Li Y; Liu Y; Wang J; Li Y; Li G
Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):224-9. PubMed ID: 20213048
[TBL] [Abstract][Full Text] [Related]
38. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
Wang YF; Zhang S; Li XQ; Wang Y
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
[TBL] [Abstract][Full Text] [Related]
39. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
